» Articles » PMID: 2943285

Bile Flow Decrease and Altered Bile Composition in Streptozotocin-treated Rats

Overview
Date 1986 Aug 1
PMID 2943285
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effects of Diabetes Mellitus on the Disposition of Tofacitinib, a Janus Kinase Inhibitor, in Rats.

Gwak E, Yoo H, Kim S Biomol Ther (Seoul). 2020; 28(4):361-369.

PMID: 32209733 PMC: 7327145. DOI: 10.4062/biomolther.2020.006.


Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.

Arboatti A, Lambertucci F, Sedlmeier M, Pisani G, Monti J, Alvarez M Biomed Res Int. 2018; 2018:9472939.

PMID: 29850590 PMC: 5937583. DOI: 10.1155/2018/9472939.


Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.

Srinivas N Eur J Drug Metab Pharmacokinet. 2014; 40(1):1-12.

PMID: 24596068 DOI: 10.1007/s13318-014-0186-9.


Study of the pharmacokinetic changes of Tramadol in diabetic rats.

Lavasani H, Sheikholeslami B, Ardakani Y, Abdollahi M, Hakemi L, Rouini M Daru. 2013; 21(1):17.

PMID: 23497674 PMC: 3610115. DOI: 10.1186/2008-2231-21-17.


Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.

Kim Y, Lee J, Kim S, Lee M Antimicrob Agents Chemother. 2005; 49(6):2528-32.

PMID: 15917564 PMC: 1140488. DOI: 10.1128/AAC.49.6.2528-2532.2005.